91 related articles for article (PubMed ID: 17386207)
1. [Calculation of coronary risk in primary care: which table is more suitable for our patients?].
Rodríguez Villar D; Muñoz Devesa L; García López UP
Aten Primaria; 2007 Mar; 39(3):145-9. PubMed ID: 17386207
[TBL] [Abstract][Full Text] [Related]
2. [The use of the Framingham-REGICOR equation in a primary care centre. Impact on primary prevention of cardiovascular diseases].
Parrilla Valero F; Segura Benedicto A; Segú Tolsa JL
Aten Primaria; 2006 Nov; 38(9):490-5. PubMed ID: 17194352
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of coronary risk estimates derived using the Framingham and REGICOR equations].
Cristóbal J; Lago F; de la Fuente J; González-Juanatey JR; Vázquez-Bellés P; Vila M
Rev Esp Cardiol; 2005 Aug; 58(8):910-5. PubMed ID: 16053824
[TBL] [Abstract][Full Text] [Related]
4. [Validation of 3 equations of coronary risk in diabetic population of a primary care center].
Cañón-Barroso L; Cruces-Muro E; Fernández-Ochoa G; Nieto-Hernández T; García-Vellido A; Buitrago F
Med Clin (Barc); 2006 Apr; 126(13):485-90. PubMed ID: 16624226
[TBL] [Abstract][Full Text] [Related]
5. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
[TBL] [Abstract][Full Text] [Related]
6. Impact of using different SCORE tables for estimating cardiovascular risk.
Brotons C; Moral I; Soriano N; Cuixart L; Osorio D; Bottaro D; Puig M; Joaniquet X; Marcos A; Casasa A
Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):94-100. PubMed ID: 24795115
[TBL] [Abstract][Full Text] [Related]
7. Consequences of using different methods to assess cardiovascular risk in primary care.
Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
[TBL] [Abstract][Full Text] [Related]
8. [Do the patients we treat with hypolipemic drugs have a coronary risk?].
Vilaseca Canais J; Buxeda Mestres C; Cámara Contreras C; Flor Serra F; Pérez Guinaldo R; Sánchez Viñas M
Aten Primaria; 1997 Jun; 20(1):49-53. PubMed ID: 9303663
[TBL] [Abstract][Full Text] [Related]
9. [Appropriateness of lipid-lowering treatment and cardiovascular risk in patients with hypercholesterolemia].
Segade Buceta XM; Dosil Díaz O
Gac Sanit; 2002; 16(4):318-23. PubMed ID: 12106551
[TBL] [Abstract][Full Text] [Related]
10. [Predictive capacity, comparison and clinic consequences of the Framingham-Wilson and REGICOR tables in persons for whom care has been provided at a health care center, Badajoz, Spain].
Cañón Barroso L; Díaz Herrera N; Cruces Muro E; Nieto Hernández T; Garrote Florencio T; Buitrago F
Rev Esp Salud Publica; 2007; 81(4):353-64. PubMed ID: 18041538
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of population coronary heart disease risk estimated by the Framingham original and REGICOR calibrated functions].
Ramos R; Solanas P; Cordón F; Rohlfs I; Elosua R; Sala J; Masiá R; Faixedas MT; Marrugat J
Med Clin (Barc); 2003 Oct; 121(14):521-6. PubMed ID: 14599406
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
[TBL] [Abstract][Full Text] [Related]
13. Muscle Mass and Body Fat in Relation to Cardiovascular Risk Estimation and Lipid-Lowering Eligibility.
Lee K
J Clin Densitom; 2017; 20(2):247-255. PubMed ID: 27939251
[TBL] [Abstract][Full Text] [Related]
14. A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction.
Ramachandran S; Croft P; Neary RH
Prev Cardiol; 2003; 6(1):17-21. PubMed ID: 12624557
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
[TBL] [Abstract][Full Text] [Related]
16. [Different approach in high-cardiovascular-risk women, compared to men: a multidisciplinary study-Spain].
Conthe Gutiérrez P; Lobos Bejarano JM; González Juanatey JR; Gil Núñez A; Pajuelo Fernández FJ; Novials Sardá A;
Med Clin (Barc); 2003 Apr; 120(12):451-5. PubMed ID: 12689551
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the SCORE and REGICOR models for calculating cardiovascular risk in cardiovascular disease-free individuals at a healthcare center in Barcelona, Spain].
Baena Díez JM; del Val Garcia JL; Héctor Salas Gaetgens L; Sánchez Pérez R; Altes Vaques E; Deixens Martínez B; Amatller Corominas M; Katia Núñez Casillas D
Rev Esp Salud Publica; 2005; 79(4):453-64. PubMed ID: 16465962
[TBL] [Abstract][Full Text] [Related]
18. [Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population].
Gil-Guillén V; Orozco-Beltrán D; Maiques-Galán A; Aznar-Vicente J; Navarro J; Cea-Calvo L; Quirce-Andrés F; Redón J; Merino-Sánchez J
Rev Esp Cardiol; 2007 Oct; 60(10):1042-50. PubMed ID: 17953925
[TBL] [Abstract][Full Text] [Related]
19. [Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?].
Aleksić E; Stamenković R; Lapcević M; Deljanin-Ilić M; Djordjević D; Tasić I
Srp Arh Celok Lek; 2011; 139(1-2):30-6. PubMed ID: 21568080
[TBL] [Abstract][Full Text] [Related]
20. The "Five Risks algorithm": an easy tool for cardiovascular risk estimation.
Devroey D; Vandevoorde J
Cent Eur J Public Health; 2009 Sep; 17(3):133-8. PubMed ID: 20020602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
